• Radionuclide candidates for β+γ coincidence PET: An overview, Sitarz M, Cussonneau J-P, Matulewicz T, Haddad F., Applied Radiation and Isotopes. janv 2020;155:108898. https://doi.org/10.1016/j.apradiso.2019.108898

  • Production of polonium from bismuth and purification using TBP resin and Sr resin, Younes A, Alliot C, Ali JS, Bonraisin A-C, Mokili M, Happel S, et al., J Radioanal Nucl Chem. mai 2020;324(2):823‑8. https://doi.org/10.1007/s10967-020-07109-5

  • Theranostic Radiopharmaceuticals : at the Inflection Point, Jean-François Chatal, Françoise Bodere-Kraeber, Caroline Rousseau, Ferid Haddad, British Journal of Cancer Research, 2019, 2 (2), pp.264-269.

  • Very high specific activity erbium 169Er production for potential receptor-targeted radiotherapy, Formento-Cavaier R, Köster U, Crepieux B, Gadelshin VM, Haddad F, Stora T, et al., Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. janv 2020;463:468‑71. https://doi.org/10.1016/j.nimb.2019.04.022

  • MELISSA : Laser ion source setup at CERN-MEDICIS facility. Blueprint, Gadelshin VM, Barozier V, Cocolios TE, Fedosseev VN, Formento-Cavaier R, Haddad F, et al., Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. janv 2020;463:460‑3. https://doi.org/10.1016/j.nimb.2019.04.024

  • Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept, Huclier-Markai S, Alliot C, Kerdjoudj R, Mougin-Degraef M, Chouin N,  Haddad F. Cancer Biother Radiopharm. 2018, 33: 316-329

  • Alphatherapy, the new impetus to targeted radionuclide therapy? Chatal JF, Kraeber-Bodéré F, Chérel M, Haddad F, Eur J Nucl Med Mol Imaging 2018, 45:1362-1363